REQUEST A DEMO
Total
USD $0.00
Search more companies

Apollo1 Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Full name: Apollo1 Sp. z o.o. Profile Updated: November 30, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Apollo1 Sp. z o.o. is based in Poland, with the head office in Katowice. The company operates in the Pharmacies and Drug Stores industry. It was first established on September 13, 2018. In 2023, the company reported a net sales revenue drop of 83.89%. There was a total negative growth of 95.6% in Apollo1 Sp. z o.o.’s total assets over the same period. The net profit margin of Apollo1 Sp. z o.o. increased by 3.79% in 2023.

Headquarters
Ul. 3 Maja 22/2C
Katowice; Slaskie; Postal Code: 40-096

Contact Details: Purchase the Apollo1 Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Apollo1 Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Apollo1 Sp. z o.o. report to view the information.
Incorporation Date:
September 13, 2018
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Apollo1 Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-83.89%
Total operating revenue
-83.89%
Operating profit (EBIT)
91.82%
Net Profit (Loss) for the Period
91.82%
Total assets
-95.6%
Total equity
-51.36%
Operating Profit Margin (ROS)
3.79%
Net Profit Margin
3.79%
Return on Equity (ROE)
522.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?